A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients with a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis - HELICON

Study identifier:ME-CV-1302

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Retrospective Swedish Cohort Study on Health Outcomes, Life Expectancy, Resource Use and Costs in Patients with a History of Myocardial Infarction and Additional Risk Factors for Atherothrombosis

Medical condition

Acute Coronary Syndrome

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

100000

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Aug 2013
Primary Completion Date: 01 Nov 2013
Study Completion Date: 01 Nov 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 May 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria